- Home
- ELDN vs TLS Comparison
ELDN vs TLS Comparison
Compare ELDN & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- TLS
- Stock Information
- Founded
- ELDN 2004
- TLS 1969
- Country
- ELDN United States
- TLS United States
- Employees
- ELDN N/A
- TLS N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- TLS EDP Services
- Sector
- ELDN Health Care
- TLS Technology
- Exchange
- ELDN Nasdaq
- TLS Nasdaq
- Market Cap
- ELDN 178.4M
- TLS 185.9M
- IPO Year
- ELDN N/A
- TLS 2020
- Fundamental
- Price
- ELDN $2.72
- TLS $2.52
- Analyst Decision
- ELDN Strong Buy
- TLS Buy
- Analyst Count
- ELDN 2
- TLS 6
- Target Price
- ELDN $12.50
- TLS $3.94
- AVG Volume (30 Days)
- ELDN 198.6K
- TLS 434.3K
- Earning Date
- ELDN 08-18-2025
- TLS 08-08-2025
- Dividend Yield
- ELDN N/A
- TLS N/A
- EPS Growth
- ELDN N/A
- TLS N/A
- EPS
- ELDN N/A
- TLS N/A
- Revenue
- ELDN N/A
- TLS $109,269,000.00
- Revenue This Year
- ELDN N/A
- TLS $35.76
- Revenue Next Year
- ELDN N/A
- TLS $26.83
- P/E Ratio
- ELDN N/A
- TLS N/A
- Revenue Growth
- ELDN N/A
- TLS N/A
- 52 Week Low
- ELDN $2.30
- TLS $1.83
- 52 Week High
- ELDN $5.54
- TLS $4.82
- Technical
- Relative Strength Index (RSI)
- ELDN 35.43
- TLS 41.90
- Support Level
- ELDN $2.76
- TLS $2.48
- Resistance Level
- ELDN $2.90
- TLS $2.88
- Average True Range (ATR)
- ELDN 0.16
- TLS 0.12
- MACD
- ELDN -0.03
- TLS -0.02
- Stochastic Oscillator
- ELDN 4.39
- TLS 2.67
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.